PODXL in promoting cancer cell proliferation and survival against chemotherapy and immunotherapy drugs has also be shown in nonepithelial cancers, such as astrocytoma, osteosarcoma, and mature B-cell lymphoma cells. Here, PODXL is linked to osteosarcoma.